Effective treatment with dupilumab may allow younger children with severe atopic dermatitis and short stature to catch up on ...

A new study published in the Journal of American Academy of Dermatology found that Dupilumab improved atopic dermatitis (AD) ...

Moreover, diabetes was linked with a nearly fourfold increase in pulmonary fibrosis among patients with RA (OR 3.704, 95% CI ...

Barbara Paldus is the founder of biotech company Codex Labs and an expert on all things skincare, skin health and skin ...

The following is a summary of “Clinical Effectiveness and Safety of Dupilumab in Chronic Obstructive Pulmonary Disease ...

Dupilumab, an injectable interleukin (IL)-4 and IL-13 pathway inhibitor, recently received FDA approval as the first-ever ...

Kymera Therapeutics Inc. has received IND clearance from the FDA for KT-621, an investigational first-in-class, once-daily, oral STAT6 degrader.

Learn how dupilumab significantly improves quality of life in COPD patients with type 2 inflammation, according to phase 3 ...

KT-621 has demonstrated dupilumab-like activity and was well tolerated ina wide variety of preclinical models of TH2 diseasesKT-621 is expected ...

In a major potential step toward personalized therapy for atopic dermatitis, data suggest early, late, and no clinical ...

The separation of Ebglyss from Dupixent and Adbry/Adtralza will depend on real-world clinical benefits, patient experience ...